What it is & primary uses
A cartilage glycosaminoglycan studied for osteoarthritis symptoms, with formulation and guideline disagreement.
Main benefits
- Some trials of pharmaceutical-grade products report modest knee symptom improvement.
- Results vary by product quality and major clinical guidelines do not fully agree.
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
800–1,200 mg/day chondroitin sulfate
- Study duration
- Commonly 4–12 weeks; protocol and outcome vary
- Interpretation
- Results vary by product quality and major clinical guidelines do not fully agree.
04Food sources & equivalents＋
Can food provide a studied amount?
Chondroitin Sulfate in this supplemental form does not have a reliable one-to-one food equivalent.
Dietary exposure; verify composition before comparing with a studied supplement dose
- How this was estimated
- Dose Radar compares the declared active ingredient with official composition data or the studied standardized extract—not with marketing names.
- Important limitation
- Natural content, preparation, bioavailability and formulation vary. This comparison does not prove equal physiological effect.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: NCCIH glucosamine and chondroitin evidence summary ↗05How to take it for absorption & tolerance＋
With food
Food commonly improves gastrointestinal tolerance, although it can change absorption for some ingredients.
- Practical approach
- With food, once daily or divided. Keep the formulation and daily total consistent with the evidence context shown above.
- Watch for
- Warfarin and other anticoagulants
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: NCCIH glucosamine and chondroitin evidence summary ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Moderate evidence for the stated context. Results vary by product quality and major clinical guidelines do not fully agree.
The displayed amount comes from human research or an official evidence summary. It is not a personalized prescription, and formulation can change whether the comparison is valid.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
NCCIH glucosamine and chondroitin evidence summary
Dose context: 800–1,200 mg/day chondroitin sulfate
Some trials of pharmaceutical-grade products report modest knee symptom improvement. Results vary by product quality and major clinical guidelines do not fully agree.
Chondroitin Sulfate: live PubMed review search
Dose context: Ingredient-specific human literature; dose and formulation vary
This live index supports source verification. A new paper does not change the Dose Radar grade until its design, population and formulation are reviewed.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.
Dose Radar will leave this lane empty rather than invent or infer a professional opinion.